Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bovogen Biologicals is an Australian biotechnology manufacturing company focused on animal-derived biological ingredients and related bioprocessing services for the life sciences sector. The company manufactures and supplies specialty animal serums, purified animal proteins, enzymes, and related products used in pharmaceutical, vaccine, diagnostics, veterinary, biotechnology, research, and nutritional applications. Its core portfolio includes bovine serum albumin and other purified bovine proteins, supported by sterile filtration, lyophilisation, and OEM/contract bioprocess manufacturing capabilities. Founded in 2001 in Melbourne, the company scaled commercial BSA manufacturing in 2003, expanded into sterile-filtered serum manufacturing in 2009, and was acquired by ANZCO Foods in late 2016 as part of ANZCO’s vertically integrated healthcare strategy. Bovogen operates with ISO-certified quality systems, EDQM certification for selected products, and GMP-aligned manufacturing processes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bovogen Biologicals.